Literature DB >> 2391586

Analysis of T-cell receptor and immunoglobulin gene rearrangements in the diagnosis of Hodgkin's and non-Hodgkin's lymphoma.

S Gledhill1, A S Krajewski, A E Dewar, D E Onions, R F Jarrett.   

Abstract

The results of genotypic analysis of 29 cases of malignant lymphoma are reported and the application of this technique for differentiating between Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL) is evaluated. Five cases with a differential diagnosis which included HD and NHL were analysed. These results are compared with those obtained for six B-cell NHLs, nine T-cell NHLs, and nine cases of HD. This report suggests that gene rearrangement analysis is useful in some cases in which the differential diagnoses includes HD and NHL as the absence of gene rearrangements is more consistent with a diagnosis of HD than of NHL. Two monoclonal antibodies reactive with the variable region of T-cell receptor beta-chain and molecular probes to the relevant variable region genes were used to assist in the diagnosis of T-cell lymphoma. This report confirms that genotypic analysis is useful diagnostically when the results are assessed in the context of the histopathological findings.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391586     DOI: 10.1002/path.1711610312

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  3 in total

1.  Analysis of antigen receptor genes in Hodgkin's disease.

Authors:  C A Angel; J H Pringle; J Naylor; K P West; I Lauder
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

2.  Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease.

Authors:  A A Armstrong; L Shield; A Gallagher; R F Jarrett
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

3.  Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples.

Authors:  S Gledhill; A Gallagher; D B Jones; A S Krajewski; F E Alexander; E Klee; D H Wright; C O'Brien; D E Onions; R F Jarrett
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.